Skip to main content

You are currently viewing a beta version of this site; please send improvements to contact@openomb.org.

NIH Innovation, CURES Act

Schedules

TAFS: 075-5628 /X - NIH Innovation, CURES Act

Iterations:
Adjustment authority: Yes
Reporting categories: No
Previously Approved (Iteration 2)Current OMB Action (Iteration 3)
Line #SplitDescriptionAmount FootnotesAmountFootnotes
1000DADiscretionary Actual - Unob Bal: Brought forward, Oct 1$25,617,228.00 See footnotes below $25,617,228.00 See footnotes below
Footnotes for line 1000 (DA) (Previous):

B1: Pursuant to P. L. 117-328 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended.

Footnotes for line 1000 (DA) (Current):

B1: Pursuant to P. L. 117-328 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended.

1021Unob Bal: Recov of prior year unpaid obligations$623,665.00 $634,832.00
1000DEDiscretionary Expected - Unob Bal: Brought forward, October 1 Line removed
1061Unob Bal: Antic recov of prior year unpd/pd obl$5,876,335.00 $5,865,168.00
1101BA: Disc: Appropriation (special or trust)$407,000,000.00 See footnotes below $407,000,000.00 See footnotes below
Footnotes for line 1101 (Previous):

B2: Pursuant to PL 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $407,000,000 to remain available until expended.

Footnotes for line 1101 (Current):

B2: Pursuant to PL 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $407,000,000 to remain available until expended.

1134BA: Disc: Appropriations precluded from obligation-$268,009,500.00 See footnotes below
Footnotes for line 1134 (Previous):

B3: Amount on line 1134 has been adjusted pursuant to OMB Bulletin 23-02.

1151BA: Disc: Appropriations:Antic nonexpend trans net-$58,738,000.00 See footnotes below -$172,000,000.00 See footnotes below
Footnotes for line 1151 (Previous):

B4: Pursuant to P.L. 118-15, P.L. 118-22, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001.

Footnotes for line 1151 (Current):

B3: Pursuant to P.L. 118-15, P.L. 118-22, P.L. 118-35, P.L. 118-40, P.L. 118-47 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001.

1920Total budgetary resources avail (disc. and mand.)$112,369,728.00 See footnotes below $267,117,228.00 See footnotes below
Footnotes for line 1920 (Previous):

B5: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals.

Footnotes for line 1920 (Current):

B4: Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals.

6011NIH Innovation, CURES Act$112,369,728.00 $267,117,228.00
6190Total budgetary resources available$112,369,728.00 See footnotes below $267,117,228.00 See footnotes below
Footnotes for line 6190 (Previous):

A1: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

A2: Funds appropriated by P.L.118-15 and P.L.118-22 were apportioned to this account by OMB Bulletin 23-02. In the event of an extension of that continuing resolution beyond February 2, 2023, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes for line 6190 (Current):

A1: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
B1
Pursuant to P. L. 117-328 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended.
B2
Pursuant to PL 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $407,000,000 to remain available until expended.
B3
Pursuant to P.L. 118-15, P.L. 118-22, P.L. 118-35, P.L. 118-40, P.L. 118-47 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001.
B4
Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals.

The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.

NumberText
A1
The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
A2
Funds appropriated by P.L.118-15 and P.L.118-22 were apportioned to this account by OMB Bulletin 23-02. In the event of an extension of that continuing resolution beyond February 2, 2023, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
B1
Pursuant to P. L. 117-328 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended.
B2
Pursuant to PL 114-255, section 1001, NIH CURES Act innovation projects are funded in the amount of $407,000,000 to remain available until expended.
B3
Amount on line 1134 has been adjusted pursuant to OMB Bulletin 23-02.
B4
Pursuant to P.L. 118-15, P.L. 118-22, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001.
B5
Pursuant to section 120.21 of OMB Circular A-11, one or more lines in the Budgetary Resources section may be rounded up. As a result, those rounded lines will not match the actuals reported on the SF 133. Agency will ensure that its funds control system will only allot actuals.

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.